Potential new treatment for SRI-resistant patients with depression

S-adenosyl methionine (SAMe), a naturally occurring molecule, may be an effective treatment for patients with depression who don’t respond to serotonin reuptake inhibitors (SRIs) according to a study of 73 patients in the American Journal of Psychiatry. Read more here.

LEAVE A REPLY

Please enter your comment!
Please enter your name here